United States set
Menu Shopping cart $0 Search
Manufactured by BioVendor

Human Monomeric CRP (mCRP) ELISA

  • Regulatory status:RUO
  • Type:Sandwich ELISA
  • Other names:mCRP, monomeric C-reactive protein
  • Species:Human
Cat. No. Size Price

New RBL010R 96 wells (1 kit) $586,5
PubMed Product Details
Technical Data


Sandwich ELISA


Serum, Plasma

Sample Requirements

50 µl/well


Shipped on blue ice packs. Upon receipt, store the product at the temperature recommended below.


Store the complete kit at 2–8°C. Under these conditions, all components are stable until the expiration date (see label on the box).

Calibration Range

1.25 - 80 ng/ml

Limit of Detection

0.63 ng/ml

Intra-assay (Within-Run)

n = 8
CV = 6.2%

Inter-assay (Run-to-Run)

n = 8
CV = 9.8%

Spiking Recovery


Dilution Linearity




It is intended for research use only

The total assay time is less than 20 hours

The kit measures monomeric CRP , there is no reactivity with pentameric CRP

Assay format is 96 wells

Quality Controls are human serum based

Standard is a recombinant protein

Components of the kit are provided ready to use, concentrated or dried

Research topic

Cardiovascular disease, Coronary artery disease, Neurodegenerative disease


C-reactive protein (CRP) is a multipotent protein that undergoes conformational changes between circulating native pentameric CRP (pCRP), pentameric symmetrical forms (pCRP*) and monomeric CRP (mCRP) forms. mCRP exhibits strong pro-inflammatory activity and activates platelets, leukocytes, and endothelial cells. Abundant deposition of mCRP in inflamed tissues plays a role in several disease conditions, such as ischemia/reperfusion injury, Alzheimer’s disease, and cardiovascular disease. Conversion of pCRP to mCRP induces inflammatory signalling, monoacyl phosphatidylcholine generated by PLA2, or by oxidation lipid acyl chains, promotes binding and dissociation of pCRP to mCRP. mCRP gains functionally active neoepitopes that carry out highly pro-inflammatory and pro-thrombotic features, thus mCRP can bind cholesterol and enter plasmatic membrane and activate pro-inflammatory responses. Deposition of mCRP, which has a much lower aqueous solubility than pCRP, has been shown in the brain in infarcted areas of Alzheimer diseases patients and in regions with amyloid burden, in atherosclerotic plaques in vascular disease and in other foci of inflammatory tissue injuries.

Related Products Docs